Archive for March 22nd, 2012

TLON receives positive ODAC vote. AVII files shelf. CYTR reverse split vote date set + MNOV news

Mar 22, 2012 No Comments by

Talon Therapeutics, Inc., (OTCBB:TLON), announced the Oncologic Drugs Advisory Committee voted 7 yes, 4 no, and 2 abstain for a  favorable benefit/risk assessment for use of Marqibo for the treatment of adult Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL) in second or greater relapse or that has progressed following two or more lines of anti-leukemia therapy. The PDUFA date for […]

Daily News Read more